Edition:
India

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

515.60INR
22 Jun 2018
Change (% chg)

Rs-6.35 (-1.22%)
Prev Close
Rs521.95
Open
Rs516.85
Day's High
Rs532.00
Day's Low
Rs510.15
Volume
189,651
Avg. Vol
107,597
52-wk High
Rs589.40
52-wk Low
Rs414.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 8,533.10 4.980
Dec 8,400.20 6.930
Sep 7,892.90 6.450
Jun 6,481.90 3.540
FY 2017 Mar '17 7,413.50 4.935
Dec 7,770.30 4.591
Sep 8,794.20 6.356
Jun 7,413.50 4.940
FY 2016 Mar '16 6,265.80 4.796
Dec 9,308.90 14.262
Sep 10,180.70 15.304
Jun 5,904.60 3.805
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 8,631.00 8,631.00 8,631.00 10,030.00
Quarter Ending Dec-18 1 9,400.00 9,400.00 9,400.00 9,833.00
Year Ending Mar-18 14 31,211.20 32,053.00 30,333.90 --
Year Ending Mar-19 16 34,955.00 35,952.00 31,619.00 41,774.40
Year Ending Mar-20 15 39,835.60 42,984.00 38,199.00 43,596.00
Earnings (per share)
Quarter Ending Sep-18 1 5.71 5.71 5.71 4.45
Quarter Ending Dec-18 1 6.14 6.14 6.14 7.56
Year Ending Mar-18 14 23.12 24.80 21.76 --
Year Ending Mar-19 16 23.56 25.70 20.20 32.44
Year Ending Mar-20 15 27.69 31.80 24.80 28.84
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 25.87 30.95 32.74
P/E High - Last 5 Yrs. 30.29 40.70 45.73
P/E Low - Last 5 Yrs. 11.98 23.63 24.23
Beta 0.37 0.89 0.88
Price to Sales (TTM) 3.11 3.94 5.71
Price to Book (MRQ) -- 4.81 5.37
Price to Tangible Book (MRQ) -- 5.61 6.94
Price to Cash Flow (TTM) 20.95 22.91 23.32
% Owned Institutions -- 1.21 2.17

Dividends

  Company industry sector
Dividend Yield 0.80 1.56 1.50
Dividend Yield - 5 Year Avg 0.82 1.57 1.51
Dividend 5 Year Growth Rate 23.36 4.47 5.32
Payout Ratio(TTM) 20.60 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -12.57 2.24 7.89
Sales (TTM) vs TTM 1 Yr. Ago -8.17 4.83 5.68
Sales - 5 Yr. Growth Rate 16.42 10.08 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -28.34 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago -50.58 -- --
EPS - 5 Yr. Growth Rate 25.38 9.88 10.78
Capital Spending - 5 Yr. Growth Rate 50.33 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) -- 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.19
Total Debt to Equity (MRQ) -- 13.86 16.46
Interest Coverage (TTM) 144.16 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.56 54.81 54.46
Gross Margin - 5 Yr. Avg. 62.28 52.15 52.22
EBITD Margin (TTM) 18.36 -- --
EBITD - 5 Yr. Avg 22.40 18.57 10.98
Operating Margin (TTM) 15.55 14.36 4.74
Operating Margin - 5 Yr. Avg. 20.06 14.52 6.41
Pre-Tax Margin (TTM) 15.46 14.82 5.58
Pre-Tax Margin - 5 Yr. Avg. 19.94 14.91 6.83
Net Profit Margin (TTM) 12.04 11.08 1.88
Net Profit Margin - 5 Yr. Avg. 15.42 11.20 3.10
Effective Tax Rate (TTM) 22.16 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. 22.67 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,451,547 938,104,300 846,855,748
Net Income/Employee (TTM) 415,467 110,371,256 99,619,396
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.40 10.95
Return on Assets - 5 Yr. Avg. 22.27 12.91 12.32
Return on Investment (TTM) -- 14.84 14.38
Return on Investment - 5 Yr. Avg. 34.14 16.88 16.11
Return on Equity (TTM) -- 16.34 16.08
Return on Equity - 5 Yr. Avg. 37.31 17.98 17.41
  1 Year 3 Year 5 Year
Sales % -0.99 18.93 16.42
EPS (TTM) % -44.01 19.63 25.38
Dividend % 0.00 10.06 23.36
Note: Units in Millions of US Dollars

Performance for Alembic Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.62 0.22 99 25
13 Week -2.90 -4.28 99 35
26 Week -19.09 -24.45 98 29
52 Week -25.95 -34.58 84 12
YTD -15.58 -29.34 98 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.52%
# of Holders: 37
Total Shares Held: 23,608,220
3 Mo. Net Change: 398,642
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 11
# Reduced Positions: 8
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.